AR016087A1 - Derivados 5-substituidos-1,2,4-tiadiazolilo inhibidores de angiogenesis, procedimientos para su preparacion, su uso como medicina, composicionfarmaceutica que los comprenden, procedimientos para su preparacion, compuesto intermediario y procedimiento para su preparacion. - Google Patents
Derivados 5-substituidos-1,2,4-tiadiazolilo inhibidores de angiogenesis, procedimientos para su preparacion, su uso como medicina, composicionfarmaceutica que los comprenden, procedimientos para su preparacion, compuesto intermediario y procedimiento para su preparacion.Info
- Publication number
- AR016087A1 AR016087A1 ARP980103020A ARP980103020A AR016087A1 AR 016087 A1 AR016087 A1 AR 016087A1 AR P980103020 A ARP980103020 A AR P980103020A AR P980103020 A ARP980103020 A AR P980103020A AR 016087 A1 AR016087 A1 AR 016087A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- preparation
- alkyloxy
- amino
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/83—Thioacids; Thioesters; Thioamides; Thioimides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Derivados 5 sustituido-1,2,4-tiadiazolilo inhibidores de angiogénesis que tienen la formula I las formas de N-oxido, las sales de adicion de ácidofarmacéuticamente aceptables y las formas estereoquímicamente isoméricas de los mismos donde X es CH oN ; R1 es hidrogeno, alquilo C1-6, alquiloxi C1-6,alquiltio C1-6, amino, mono o di(alquilo C1-6)amino, Ar1, Ar1-NH-, cicloalquilo C3-6, hidroximetilo, o benciloximetilo; R2 es hidrogeno, alquilo C1-6 amino,aminocarbonilo, mono o di (alquilo C1-6)amino , alquiloxicarbonilo C1-6, alquilcarbonilamino C1-6, hidroxi o alquiloxi C1-6; R3, R4 y R5 están cada unoindependientemente seleccionados de hidrogeno, halo, alquilo C1-6, alquiloxi C1-6, trifluormetilo, nitro, amino, ciano, azido, alquiloxiC1-6, a lquilo C1-6,alquiltio C1-6, alquiloxicarbonilo C1-6, Het1; A es Ar2, Ar2-CH2-o Het2, Ar1 es fenilo, fenilo sustituido con 1, 2 o 3 sustituyentes cada uno de ellosindependientemente seleccionado de halo, alquilo C1-6, alquiloxi C1-6,trialometilo, ami no o nitro y Ar2 es fenilo substituido con 1, 2 o 3 substituyentes cadauno de ellos independientemente seleccionado de halo, alquilo C1-6, alquiloxi C1-6, trialometilo, amino o nitro, Het1 es un heterocíclico monocíclico queestáseleccionado de oxazo lilo,isoxazolilo,oxadiazolilo,tiazolilo,isotiazolilo,tidiazolilo o oxazolinilo, y cada heterocíclo monocíclico puede estar opcionalmentesustituido en un átomo de carbono de alquilo C1-4; y Het2 es un heterociclo monocíclicoque está seleccionado de f uranilo, tiofuranilo, oxadiazolilo,tiadiazolilo, piridinilo, pirimidinilo o pirazinilo y cada heterociclo monociclico puede estar opcionalmente sustituido en un átomo de carbono con uno o dossustituyentes cada uno de ellosindependientemente seleccio nado de halo, alquilo C1-4, alquilo C1-4 nitro o trifluormetilo procedimiento para su preparacion,composicion que los contienen, procedimiento para su preparacion, su uso como medicina, compuesto intermediario yprocedimiento para su preparacion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201931 | 1997-06-24 | ||
US5300397P | 1997-07-10 | 1997-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016087A1 true AR016087A1 (es) | 2001-06-20 |
Family
ID=26146629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980103020A AR016087A1 (es) | 1997-06-24 | 1998-06-23 | Derivados 5-substituidos-1,2,4-tiadiazolilo inhibidores de angiogenesis, procedimientos para su preparacion, su uso como medicina, composicionfarmaceutica que los comprenden, procedimientos para su preparacion, compuesto intermediario y procedimiento para su preparacion. |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR100534621B1 (es) |
AR (1) | AR016087A1 (es) |
NO (1) | NO314804B1 (es) |
TW (1) | TW510901B (es) |
-
1998
- 1998-06-22 KR KR10-1999-7010983A patent/KR100534621B1/ko not_active IP Right Cessation
- 1998-06-23 AR ARP980103020A patent/AR016087A1/es not_active Application Discontinuation
- 1998-06-24 TW TW087110129A patent/TW510901B/zh not_active IP Right Cessation
-
1999
- 1999-12-22 NO NO19996392A patent/NO314804B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
TW510901B (en) | 2002-11-21 |
KR100534621B1 (ko) | 2005-12-08 |
NO996392D0 (no) | 1999-12-22 |
KR20010013009A (ko) | 2001-02-26 |
NO314804B1 (no) | 2003-05-26 |
NO996392L (no) | 1999-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR032360A1 (es) | Compuesto derivado de acido homoiminopiperidinil hexanoico, composicion farmaceutica que lo comprende y compuestos intermediarios que se usan en su preparacion | |
AR050540A1 (es) | Derivados de adamantilamida triciclica como inhibidores de deshidrogenasa 11- beta hidroxiesteroide | |
AR037329A1 (es) | Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos | |
AR032679A1 (es) | Derivados del acido isoftalico como inhibidores de metaloproteinasas de la matriz | |
AR053232A1 (es) | Derivados de piridina condensadas, composiciones farmaceuticas que los contienen y su empleo en la fabricacion de agentes terapeuticos antiinflamatorios y para el tratamiento de enfermedades relacionadas con el sistema inmunologico. | |
BR1100931A (pt) | Compostos derivados de aril-heteroaril carbinóis, processos para a preparação dos compostos, composições farmacêuticas, e, uso dos compostos derivados de aril-heteroaril carbinóis | |
AR012489A1 (es) | Tiofenopiridinas antagonistas del factor de liberacion de corticotropina. procedimiento para su preparacion, el uso de las mismas en la preparacionde un medicamento, composicion farmaceutica que las comprende, procedimiento para la preparacion de dicha composicion, un compuesto intermediario y | |
DK0620216T3 (da) | Benzamidderivater og deres anvendelse som vasopressinantagonister | |
ES2188194T3 (es) | 1,8-naftiridin-4(1h)-onas sustituidas como inhibidores de la fosfodiesterasa 4. | |
DE60322359D1 (de) | Imidazopyridinderivate als kinaseinhibitoren | |
DK0705254T3 (da) | Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer | |
AR032361A1 (es) | Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos | |
AR002241A1 (es) | Derivado de 2,4-oxazolidinadiona, composicion farmaceutica que lo comprende y metodo de preparacion del mismo. | |
CO5261634A1 (es) | Derivados de nicotinamida benzocondensada-heterociclico utiles como inhibidores selectivos de las isozimas pde4 | |
AR054000A1 (es) | Compuesto de n-(fenilpropil)-sulfonamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento, producto de combinacion que comprende dicho compuesto y metodo para prepararlo | |
NO883487D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
UY26454A1 (es) | Cristal de 4-carboxamino-1,2,3,4-tetrahidroquinolina 2-sustituida | |
NO994900L (no) | Forbindelser | |
AR035230A1 (es) | Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos | |
AR045793A1 (es) | Compuestos derivados de 3-heterociclil-indol | |
AR005279A1 (es) | Derivados 1-(piperidinil 1,2-disustituido)-4-(bencimidazolil e imidazopiridinil)-piperidina, proceso para su preparacion, composicion farmaceutica, y proceso para preparar dicha composicion | |
DK441180A (da) | 2-hydroxyalkyl-3,4,5-trihydroxypiperidiner deres fremstilling og anvendelse | |
AR030416A1 (es) | COMPUESTO DERIVADO HALOGENADO DEL ACIDO 2-AMINO-3,4 HEPTENOICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y SU USO EN LA FABRICACION DE UN MEDICAMENTO uTIL COMO INHIBIDOR DE LA OXIDO NITRICO SINTETASA | |
AR016087A1 (es) | Derivados 5-substituidos-1,2,4-tiadiazolilo inhibidores de angiogenesis, procedimientos para su preparacion, su uso como medicina, composicionfarmaceutica que los comprenden, procedimientos para su preparacion, compuesto intermediario y procedimiento para su preparacion. | |
DK421183D0 (da) | Fremgangsmade til fremstilling af alfa-aryl-alfa-pyridylalkansyrer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |